All leishmaniasis articles
-
NewsERC Starting Grant for Tom Beneke: Drug resistance in tropical parasites
Molecular biologist Dr Tom Beneke (35) from the Biozentrum at the University of Würzburg has been awarded a €1.5 million ERC grant to further advance his research on Leishmania and the disease they cause.
-
NewsLeishmania: When tropical parasites use immune cells as a taxi
Tom Beneke intends to clarify, as part of the new Emmy Noether Research Group ‘LeishMove’, exactly how the Leishmania parasites control their host cells and which variations in the parasites are necessary for this.
-
NewsResearchers to tackle overlooked tropical disease
Two researchers are teaming up to build foundational knowledge concerning leishmaniasis, a common, but neglected protozoan parasitic disease. The project combines research into the cell biology of membrane repair with parasitology knowledge.
-
NewsNew vaccine offers hope against growing tropical disease in U.S.
Researchers have developed a first-ever vaccine against leishmaniasis, a disease putting 10% of the world at risk. A game changer was the development of CRISPR gene-editing technology.
-
NewsPhase 1 clinical trial set to begin on first leishmaniasis vaccine
A phase 1 clinical trial testing the safety of a leishmaniasis vaccine is set to begin in the coming months. The live vaccine, found to be safe in animals, is expected to be tested in humans later this year.
-
NewsInsect wing identifying app to tackle tropical disease threat
A mobile app that identifies disease-carrying insects from their wing patterns is being developed as part of a project using AI to help diagnose tropical diseases.
-
NewsA highly precise target for medications against tropical diseases
Researchers have discovered a critical vulnerability shared by the pathogens that cause African sleeping sickness, Chagas disease and leishmaniasis. The PEX38 protein plays a crucial role in the formation of certain organelles of the trypanosomes that are essential for their energy supply.
-
News$3.7 million awarded for research into sand flies, vectors of parasitic disease leishmaniasis
Professor Gideon Wasserberg at UNC Greensboro has been awarded a prestigious $3.7 million National Institutes of Health R01 grant to advance his research on controlling sand flies, the vectors of the parasitic disease leishmaniasis.
-
NewsCracking leishmaniasis: new DNA test to track infection
A new study offers an innovative way to track the spread of leishmaniasis, a parasitic disease affecting both animals and humans. Researchers developed a fast, reliable method to identify sand fly species, detect Leishmania parasites, and determine the source of their blood meals from a single sample.
-
NewsAcross eight Amazon countries, forests on Indigenous lands reduce spread of 27 diseases
New research finds that municipalities in the Amazon region closest to healthy forests on Indigenous lands face less risk from rising cases of two categories of disease: cardiovascular and respiratory diseases due to forest fires and illnesses.
-
NewsTrojan horse method gives malaria parasites a taste of their own medicine
Researchers have developed a trojan horse method that tricks malaria parasites into ingesting a fatal dose of drugs by exploiting the parasite’s need for cholesterol to survive.
-
NewsResearchers make breakthrough in bid to develop vaccines and drugs for neglected tropical disease
Scientists have developed a new, safe and effective way to infect volunteers with the parasite that causes leishmaniasis and measure the body’s immune response, bringing a vaccine for the neglected tropical disease a step closer.
-
NewsScientists develop an innovative compound effective against malaria and leishmaniasis
Initially designed for malaria, this drug shows high efficacy against leishmaniasis, representing a unique and promising breakthrough for the treatment of both infections.
-
NewsStudy reveals how leishmaniasis vaccines work at molecular level
Researchers have determined how these vaccine candidates for leishmaniasis prompt molecular-level changes in host cells that have specific roles in helping generate the immune response.
-
NewsStudy uncovers how Leishmania parasite adapts so quickly to drugs
Scientists probing the parasite’s gene expression regulation during mRNA translation have discovered how it is able to preemptively and quickly adapt and respond to drug treatments.
-
NewsLeishmania parasite manipulates organism’s defense system to keep replicating
Researchers have shown how protozoans of the genus Leishmania that cause leishmaniasis manipulate a protein that plays an essential role in the organism’s defense in order to continue to replicate, preventing the body from vanquishing the disease.